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Purpose	
Many studies in preventing adverse drug events have been researcher-driven, yet few have engaged
patients in the development of a project. This project aims to engage minority elderly patients with
multiple chronic conditions in the development of research questions and strategies to improve
medication safety.
Methods

 lderly patients (≥65 years old) who were prescribed 7 or more chronic medications were recruited
E
through a university-based aging resource network in a historically African American community in
Houston, Texas. Patients and a caregiver participated in a multidisciplinary workgroup comprised of
a physician, pharmacists, a nurse, health educators, and a social worker. Patients were engaged by
utilizing the 4 patient-centered outcomes research engagement principles. The workgroup created a
strategic plan, completed an environmental scan, identified research problems, and reviewed current
evidence-based approaches in the literature. Workgroup findings were presented to a broader audience
within a community town hall setting, and input was collected from a community-wide survey.

Results

 rom April 2018 to July 2018, 3 patients and 1 caregiver participated in 5 multidisciplinary workgroup
F
meetings. A total of 74 seniors attended the town hall meeting, and 69 completed the surveys.
The most common drug-related problems among survey participants were doubts about drug
advertisements (79%) and drug interactions (70%). Most participants (88%) were more comfortable
in receiving face-to-face counseling compared to an app or virtual visits. Findings aided in developing
3 grant proposals.

Conclusions	
This narrative provides a roadmap for conducting multidisciplinary, patient-centered participatory
research to refine research strategies in minimizing drug-related problems. (J Patient Cent Res Rev.
2021;8:113-120.)
Keywords	
drugs; side effects; adverse reactions; elderly; polypharmacy; patient-centered care; multiple chronic
conditions

A

dverse drug event (ADE), defined as injury
caused by a medical intervention related to a
drug, is a significant health problem in the United
States.1 ADE accounts for 3.5 million physician office
visits, 1 million emergency room (ER) visits, and 125,000
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hospital admissions each year.1,2 Two major independent
risk factors for ADE are old age and multiple medication
use (ie, polypharmacy).2,3 According to the U.S. Census,
the population of adults age 65 and older has increased
from 38.8 million in 2008 to 52.4 million in 2018 (a 35%
increase) and constitutes about 18% of the U.S. population.4
The racial minority percentage is also projected to
increase from 19% of the older adult population in 2008
to 34% in 2040.4 Studies have shown that elderly patients
disproportionally experience higher rates of ADE-related
ER visit (34.5% of all ADE-related ER visits are elderly)
and hospitalization (43.6% of those elderly ADE-related
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ER visits result in hospitalization) compared to any age
group.5,6 African American patients have been reported
to experience a higher risk of ADE-related deaths.4
Elderly patients have a high prevalence of polypharmacy,
with 29% taking more than 5 medications daily.7
This places nearly 1 in 22 older individuals at risk for
significant drug-drug interactions.8 Medications used for
chronic conditions such as anticoagulants, insulin, and
opioid analgesics are implicated in about 60% of ADErelated ER visits.6 Most ADEs (50%–90%) have been
reported to be type A adverse drug reactions, which are
dose-related, predictable, and preventable events caused
by known pharmacologic effects of drugs.2,9
To overcome the critical problem of ADE, the Centers for
Medicare & Medicaid Services developed regulations
and guidelines for hospitals, clinics, and nursing homes,
in partnership with patients, to promote safe medication
use.10 Medication reconciliation strategies have had
a positive impact on reducing ADEs, but the quality
of evidence has been low and the definition of ADE
lacks standardization.11,12 Most strategies to improve
medication safety have been limited to medication
education from provider to patient.13 In 2018, a
multidisciplinary workgroup comprised of leaders in
the fields of cardiovascular disease and aging concluded
that more research would be needed to improve patient
engagement and communication as well as coordination
of care for older patients with multiple comorbidities who
encounter multiple health care providers.14
To date, few studies in the literature have fully engaged
patients as research partners to identify research problems
or to design strategies for improvement. Herein, we
describe an innovative patient engagement project —
supported by the Patient-Centered Outcomes Research
Institute (PCORI) — involving African American elderly
patients with polypharmacy who reside in a single urban
community. The primary goal of this project was to identify
research problems and refine intervention strategies by
engaging minority seniors with polypharmacy in the local
community to improve medication safety.

METHODS

Patient Recruitment

This project was conducted in the Third Ward community of
Houston, Texas, from April 2018 to August 2018. The study
protocol was reviewed and approved by the institutional
review board of Texas Southern University (Houston, TX).
Third Ward is a historically African American community
(population: 14,295) located approximately 3 miles
from Houston’s Texas Medical Center. In 2015, 8% of
individuals residing in Third Ward were 65 years old or
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older, 67% were African Americans, 22% did not have a
high school diploma, and 51% had an income of <$25,000
per year.15 It is the 15th most dangerous neighborhood in
the United States, where approximately 1 in 13 individuals
becomes a victim of a violent crime every year.16
The primary participants recruited were African Americans.
To reach this specific group in Third Ward, which has
been underrepresented in research studies historically,
investigators collaborated with a university-based
geriatric community network for patient recruitment. This
community network has been active in engaging seniors
in the Third Ward and Greater Houston for over 20 years.
Prior to study recruitment, the pharmacist investigators
provided 2 free community health-screening activities at
the Third Ward Community Center and the Hobby House
(a local gathering home) to engage with local seniors.
Each health-screening activity included a presentation
about polypharmacy, a blood pressure screening, and a
comprehensive medication review.
The director of the geriatric community network assisted
with hosting a recruitment event to a senior exercise
group that met at Emancipation Park in Third Ward.
Investigators presented project goals, eligibility criteria,
time commitment, and compensation at the event.
Interested parties completed the patient partner consent
forms and the eligibility screening forms. Eligibility for
participation in the multidisciplinary workgroup included
individuals 65 years old or older who consumed 7 or more
chronic medications daily and resided in Third Ward.
The project target included recruiting 3 patients and 1
caregiver to participate in a multidisciplinary workgroup
focused on improving the safe use of medication.
The rationale for selecting a small number of patient
partners to participate in the workgroup was to build
a close relationship and trust between the researchers
and the patient partners in the exploratory stage of the
study. The patients and caregiver were termed “patient
partners” because they served as partners in the research
development. The role of patient partners was to actively
participate in each workgroup meeting. Patient partners
served as representatives of the Third Ward community at
large to share opinions about medication safety. They were
selected based on eligibility criteria and their availability
to attend workgroup meetings. If more individuals
were eligible than the target recruitment number, those
individuals would serve as alternates when a patient
partner could not attend a meeting.
Stakeholder Recruitment

Invitations were sent to local health community partners,
including city-funded community centers, faith-based
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organizations, university health-related disciplines (health
educator program and geriatric community network), and
2 prominent Texas Medical Center-affiliated institutions
(medical school and hospital) to form a multidisciplinary
workgroup consisting of a physician, nurse, pharmacists,
health educators, and social worker. The goal was to recruit
at least 1 member from each discipline along with 1 alternate
for the workgroup. The role of the physician, nurse, and
pharmacist was to provide insights into the identification
of research questions and strategies. The role of the health
educator and social worker was to serve as gateways to
patient recruitment into workgroup and town hall meetings.
Health educators were extremely resourceful about existing
health-related promotional activities in the community.
Workgroup Tasks

The overall goal of the workgroup was to engage patient
partners in identifying research problems and refining
research strategies for medication safety. The workgroup
was tasked with 4 activities: 1) create a strategic plan; 2)
complete an environmental scan and problem identification;
3) participate in comparative effectiveness review of
current evidence-based approaches; and 4) organize a
community town hall meeting to solicit input on research
strategies from a boarder group of seniors in Third Ward.
An environmental scan was guided by 3 questions modified
from the principles of the Asset-Based Community
Development process.17 The 3 discussion questions were:
1) What community resources have been most helpful for
seniors taking multiple medications to improve medication
safety? What helps you to be better informed about
how to take your medications? 2) How can the Houston
community better support seniors who take multiple
medications based on existing strengths? What are needs
not being met? 3) What help would you need the most
right now to improve medication safety? Each workgroup
member was encouraged to express his/her opinion and
had a chance to speak during the discussions.
Workgroup discussions were recorded and transcribed by
research personnel. Transcripts were evaluated by thematic
analysis to identify the common consensus of medication
safety-related problems experienced by this workgroup.
Literature Search

Project investigators conducted a literature search via
the Texas Medical Center Library One Search database
using the terms “polypharmacy,” “adverse drug events,”
“intervention,” “elderly,” “community,” and “pharmacist.”
Only primary literature and guidelines in an outpatient
community setting were included. A lay summary of
each article was presented to the workgroup, followed
by discussions in 2 workgroup meetings after research
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problem identification and before research strategy
discussion. The summary contained article citation, study
population, setting, intervention, results, and conclusion.
Patient partners provided comments and feedback on the
strategies and outcomes of the studies reviewed.
Community Town Hall and Survey

Workgroup members assisted with the design, promotion,
organization, volunteering, and execution of the
community town hall meeting. The town hall included
an introduction about patient-centered research, a report
about the workgroup activities, sharings from each
workgroup member, and a collection of community
feedback on the name of the proposed project, medicationrelated problems, and strategies obtained via a written
survey. After the presentations, participants were free
to visit booths of vendors representing a variety of
local health clinics and community organizations. Each
participant received a medication organizer (pillbox) and
a complimentary lunch.
Engagement Approach

This project was carried out based on the 4 patientcentered outcomes research engagement principles
for engaging a hard-to-reach population: reciprocal
relationships,
partnerships,
co-learning,
and
transparency-honesty-trust.18 In reciprocal relationships,
all workgroup members were viewed as equal partners
and key personnel. Investigators and workgroup members
developed a collaborative strategic plan, which described
the role of each member in the decision-making process.
As partners, workgroup members were compensated
for their time and effort in attending the workgroup
meetings. A mutually agreed contract was established
for each workgroup member, which specified hourly
pay, time commitment, and job description. The cost for
parking to attend workgroup meetings was included in
the compensation. The meeting location and time were
set according to the patient partners’ activity schedule.
Investigators traveled to patient partners’ preferred
meeting locations. Investigators and workgroup members
were selected based on expertise in their respective
disciplines and the ability to adapt to and meet the cultural
needs of this patient partner group.
In co-learning, investigators helped patient partners and
community partners to understand the research process
and patient-centered research. Peer-reviewed articles
were summarized in lay terms (ie, third-grade reading
level) and discussed with patient partners. Patient partners
and other workgroup members were actively engaged
in identifying the research problem and reviewing the
potential causes of and solutions for the research problem.

aah.org/jpcrr

115

In transparency-honesty-trust, each patient partner had
a chance to express their opinion and cast votes to make
decisions. Patient partner votes counted as twice in weight
compared to other workgroup members. Decisions made
were carried out and reported during the next meeting. Both
patient partners and investigators arrived at the meetings
on time to show respect for all attendees’ time and effort.

RESULTS

Workgroup

A total of 24 seniors attended the recruitment event. Of
those, 3 individuals and 1 caregiver were interested in
and eligible to participate in the project. The workgroup
formed consisted of those 4 participants along with 3
pharmacists, 1 physician, 1 nurse, 3 health educators,
and 1 social worker. Most workgroup members (90%)
were African Americans. All patient partners were African
American women. This collaborative workgroup consisted
of representatives from the medical school, the college of
pharmacy, the health educator program, 2 Texas Medical
Center-affiliated hospitals, and 2 community organizations.

The workgroup had meetings every other week from
June to August. Each meeting lasted for approximately 1
hour during lunchtime, of which complimentary food and
beverage were provided. Two patient participants attended
all 5 meetings; the other patient missed 2 meetings due
to a personal conflict. The physician, nurse, pharmacists,
caregiver, health educators, and social worker were in
attendance for all the meetings. Patient partners were
actively engaged in all the meetings, and examples of their
involvement are listed in Table 1.
To begin the first workgroup meeting, members played
2 ice-breaker games to meet and greet. The group
created a strategic plan consisting of the mission, goals,
project period, objectives, membership requirements,
role and expectations of workgroup members, meeting
dates, decision-making procedures, compensation,
and communication methods. The group decided that
patients’ votes would count double in the decision-making
process. The meeting location and time were based on
the participants’ schedule, either at the Emancipation

Table 1. Summary of Patient Partners’ Engagement Activities
Milestones

Patient Engagement Examples

Create a strategic plan

•P
 atient partners in the workgroup acted as key personnel for the project by
deciding on the location and time of each meeting. They suggested that the best
time to meet was after their exercise activities, and location varied according to
their exercise schedule.
•P
 atients’ votes counted double in the decision-making process of the workgroup.

Environmental scan

• Patients provided input on what has been effective in promoting medication safety
in the community. They mentioned local pharmacy, church, clinic, community
centers, radio, TV, and friends.

Problem identification

• Patient partners in the workgroup identified major problems they experience related
to adverse drug events.

Literature review

• Investigators presented short summaries of studies on interventions to improve
medication safety by using a standardized template.
• A patient partner found and communicated with the investigator a novel intervention
found on PubMed.

Community town hall meeting

•P
 atients decided on the best time, location, and name of the town hall meeting.
•P
 atient partners helped with the planning of the town hall meeting.
•P
 atient partners who participated in the workgroup shared their experiences with
peers in the panel discussion.
•P
 atients at the town hall voted to decide on the name of the project. They provided
feedback on the importance of research problems identified by the workgroup.

Identify research strategies

•P
 atient partners in the workgroup actively shared the strategies that are most
suitable for themselves and their peers.
•P
 atient participants in the town hall provided feedback on proposed strategies
through a survey.

Grant application

•P
 atient partners provided letters of support in two Patient-Centered Outcomes
Research Institute grant applications in 2019.
•P
 atient partners continued in the National Institutes of Health’s Regional Centers in
Minority Institutions grant application under community engagement core activities.
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Park community center or Texas Southern University’s
recreation center. The strategic plan was reviewed and
adopted during the second workgroup meeting for the
project period April–August 2018.
Existing resources for medication safety in the
communities identified by workgroup members included
local pharmacies, clinics, hospitals, a church (a weekly
blood pressure screen), community, university programs,
radio, TV, relatives, and friends. Patient partners shared
their interactions with pharmacists mostly through retail
chain pharmacies. They were not familiar with medication
therapy management provided by a pharmacist in the
ambulatory care clinic. Patient partners shared problems
experienced when managing multiple medications,
including experiences of having ADEs among themselves,
families, and friends. The thematic analysis identified 8
drug-related concerns and problems (Table 2).
Investigators conducted a PubMed literature search
that resulted in 6 articles to be reviewed with the
workgroup.19-24 The presentations of articles described
effective strategies to reduce drug-related problems
in elderly patients with polypharmacy, such as
comprehensive medication reviews and examples of
clinical interventions. Based on the evidence presented,
the workgroup identified 4 potential strategies that would
be appropriate for their target population (Table 3). After
the literature review discussion, 1 patient workgroup

member found and shared a peer-reviewed article in
PubMed on the use of a self-quantification system for
personal health information to the group.25 As a result,
the use of mobile app technology was added to one of
the strategies to be surveyed by town hall participants.
Community Town Hall and Survey

Workgroup members were actively involved in the
planning of the town hall meeting. They named the town
hall Ready for Action PCORI, created flyers to promote
it, provided advice on the type of promotional gifts for
attendees, and volunteered on the meeting dates. Ready
for Action PCORI had 74 participants (69 female, 5
male) in attendance and booths for 10 community health
promotional vendors from the city of Houston, private
hospitals, and university-based organizations. The meeting
began with an introduction to patient-centered research,
followed by introduction of the workgroup members.
A survey consisting of the 8 research problems and 4
potential strategies developed by the workgroup was
presented to town hall participants for review, and their
input was solicited. Participation in the survey was
voluntary. A total of 69 participants completed the survey.
The majority of participants agreed to having experienced
the following problems: multiple medications prescribed
by multiple providers, drug-drug interactions, drug
commercials, drug side effects, feeling overwhelmed
with the drug information provided, and a lack of home

Table 2. Community Town Hall Survey Respondents on Research Problems
Strongly
Agree

Agree

Neither

Disagree

Strongly
Disagree

I go to see doctors from different facilities, and each prescribes
new medications. It can get very confusing. (n=69)

23 (33%)

20 (29%)

8 (12%)

10 (14%)

8 (12%)

I am not able to know if one drug that was given by one
physician will interact with the rest of my medications. (n=68)

22 (32%)

26 (38%)

11 (16%)

7 (10%)

2 (3%)

I am not sure if the information in drug advertisements is
trustworthy or not. (n=69)

34 (49%)

21 (30%)

7 (10%)

4 (6%)

3 (4%)

The drug information given with the bottle from the pharmacy
is not helpful. It makes me feel overwhelmed. (n=69)

18 (26%)

18 (26%)

10 (14%)

19 (28%)

4 (6%)

I take a medication for a problem, but that results in a side
effect that created another problem. (n=68)

20 (29%)

22 (32%)

12 (18%)

10 (15%)

4 (6%)

My medication costs too much money. I do not take the
prescribed medications every day, and I try to save them
even if they are expired. (n=69)

19 (28%)

7 (10%)

14 (20%)

19 (28%)

10 (14%)

I forget to take my medications. (n=69)

8 (12%)

19 (28%)

14 (20%)

18 (26%)

10 (14%)

I do not have a medication list with me, so I cannot tell the
doctor what I am taking in case of an emergency. (n=68)

16 (24%)

28 (41%)

11 (16%)

8 (12%)

5 (7%)

Drug-Related Concerns and Problems*

*n<69 indicates not every participant responded to the question.
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Table 3. Survey Respondent Preferences for Research Interventions
Very
Comfortable

Comfortable

Neutral

Uncomfortable

Very
Uncomfortable

How comfortable are you to talk to
a health professional to review your
medications? (n=69)

45 (65%)

16 (23%)

4 (6%)

3 (4%)

1 (1%)

How comfortable are you in using a
medication reminder app through your
smartphone? (n=67)

15 (22%)

8 (12%)

24 (36%)

7 (10%)

13 (19%)

How comfortable are you in having a virtual
pharmacist visit through a web camera with
the help of a health educator? (n=67)

12 (18%)

11 (16%)

23 (34%)

12 (18%)

9 (13%)

How comfortable are you in having a
peer buddy or peer group to help with
medication management? (n=69)

10 (14%)

11 (16%)

25 (36%)

14 (20%)

9 (13%)

Drug-Related Concerns and Problems*

*n<69 indicates not every participant responded to the question.

medication lists. Surprisingly, the cost of medications
and forgetfulness to take chronic medications were
perceived as less-agreed problems.
Most participants (88%) were comfortable with receiving
face-to-face counseling by a health care professional. They
were less comfortable with using a medication management
app, having virtual visits with a health care professional,
or having a peer to assist with medication management.
Research Project Proposals

Based on the workgroup feedback and community
survey, investigators developed a research proposal
featuring a patient-centered intervention study to compare
comprehensive medication reviews virtually assisted
by a health educator versus face-to-face assistance. The
patient partners in this study provided letters of support to
express a willingness to serve as patient collaborators. The
proposal also expanded the setting to include Houston’s
Fifth Ward community. The proposal was submitted to
a PCORI funding opportunity in 2018 and received
comments to improve the proposal in 2019. A revised
proposal was submitted in 2019 but was not funded.
Patient partners remained engaged in the development
of a Research Centers in Minority Institutions (RCMI)
program grant from the National Institute for Minority
Health and Health Disparities. Patient partners and
workgroup members were collaborators in the community
engagement core of that grant proposal, which was
awarded by RCMI in September 2020 (2 U54 MD00760527A1). An additional R15 grant proposal was submitted
in February 2021.
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DISCUSSION

This project demonstrates a successful patient-centered
model to engage minority elderly populations with
polypharmacy in identifying problems and making shared
decisions on research strategies. Patient partners identified
7 potential ADE-related problems. They reported
confusion about receiving prescriptions from different
providers and worried about potential drug interactions.
They also noted that most medical providers prescribe
based on medication histories obtained verbally from
patients without access to their official patient charts. A
stunning 65% of town hall survey participants reported not
maintaining a home medication list and would be unable
to tell a provider what they are taking in an emergency.
The problems identified by this workgroup are similar
to those developed by professional experts from the
American College of Cardiology (ACC), the American
Geriatrics Society (AGS), and the National Institute
on Aging (NIA).14 According to the ACC/AGS/NIA
guidelines, the most critical research problem among
patients with polypharmacy is the coordination of care/
medications in patients with multiple comorbidities
managed by multiple providers.14 Further intervention
is needed to solve this critical problem to enhance
medication safety in this community.
The complexity of the medication regimen has been
associated with increased cost-related nonadherence
in the elderly population.26 About 42% of the survey
participants disagreed that their medications cost affected
adherence negatively. Patient partners in the workgroup
(with polypharmacy) also expressed a similar opinion
when ranking the most critical research problem. Our
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study was limited in that the town hall survey did not
capture the presence of drug insurance or the number of
medications taken. Cost-related nonadherence will be
higher if a patient is taking multiple medications without
insurance or with limited insurance coverage. However,
residents without insurance can apply for county discount
cards or federally qualified health centers and receive
medications with restricted formulary in minimal fees.
In a workgroup meeting, a patient partner who had
polypharmacy expressed that her medication cost was
reduced by using discount plans by Harris County and
promotions from retail pharmacies, which can cost as
little as $4 per month. A study by Watanabe et al reported
that actual cost of medication use extended beyond just
the cost of purchasing the medications.27 The estimated
cost associated with nonoptimized medication therapy
due to treatment failure was up to $528.4 billion in 2016.
Another limitation of our study was that it recruited
seniors from a community exercise/health promotion
program through the university-based geriatric
resources network. Therefore, patients who were
disabled, were bedridden, or lacked interest in exercise
and health promotion activities were not included. Most
workgroup and town hall participants were female,
and this could limit the applicability of the result to
male elderly patients. Patient partners and town hall
participants varied in literacy level and knowledge in
the use of electronic devices, and this could affect the
result of the study.
Another observation was that close to half of the survey
participants (45%) reported they disagreed that they
forgot to take their medications. The lack of perceived
forgetfulness in taking medications has been reported
and potentially due to social desirability bias, in which
patients tell the provider what they want to hear to avoid
embarrassment.28
Patient partners were fully engaged in shared decisionmaking during each meeting, and the attendance to
workgroup meetings was optimal (100% for 2 patients
and 1 caregiver, and 60% for 1 patient). This success can
be explained by clear communication in each workgroup
meeting. Health educators who were responsible for
senior activities assisted tremendously in reminding
patient partners about meetings. Each meeting date was
discussed and agreed to through face-to-face interaction
at the previous meeting. Additionally, patient partners
communicated with investigators between meetings about
ideas, articles, and questions about the upcoming meeting.
The success in having a high attendance for the
community town hall meeting was assisted by health
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educators calling each senior in the network about the
event and peer advertisements by the patient partners
in the workgroup. Patient partners were allowed to
volunteer as speakers on the panel. Some were hesitant to
join at first, but eventually, all 3 patient partners and the
caregiver partner stepped up to share their experiences in
the town hall meeting.

CONCLUSIONS

This narrative provides a roadmap for conducting
multidisciplinary, patient-centered participatory research
to answer complex clinical questions. The next step
includes refining the procedures described herein to
continuously improve community-engagement strategies
and promote shared decision-making in the development
of interventions aimed at minimizing the adverse drug
events that occur due to multiple drug therapies among
elderly patients with multiple comorbidities.
Patient-Friendly Recap
• Improper taking of medications by elderly patients
prescribed multiple drugs for multiple conditions
can lead to serious adverse events.
• With the goal of informing a research proposal
aimed at improving medication management,
authors engaged seniors from a historically African
American community to participate in workgroup
and town hall meetings.
• Common problems reported by patient partners
were doubts about drug advertisements and
interactions between drugs.
• Most seniors were more comfortable receiving faceto-face medication counseling vs app/virtual visits.
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